{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:02:30Z","timestamp":1784613750599,"version":"3.55.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000226","name":"Ontario Ministry of Health and Long-Term Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"DOI":"10.1007\/s10461-026-05237-9","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:15:09Z","timestamp":1784610909000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Uptake of Influenza, Pneumococcal, and COVID-19 Vaccines Among People Living with HIV: Findings from the Ontario HIV Treatment Network Cohort Study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7959-7078","authenticated-orcid":false,"given":"Catharine","family":"Chambers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsegaye","family":"Bekele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramandip","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Mbuagbaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthoni","family":"Ndung\u2019u","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dane","family":"Record","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Kroch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann N.","family":"Burchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"5237_CR1","unstructured":"Public Health Agency of Canada. Canadian respiratory virus surveillance report. https:\/\/health-infobase.canada.ca\/respiratory-virus-surveillance\/ (2025). Accessed 31 Jan 2025."},{"issue":"2","key":"5237_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/cid\/civ803","volume":"62","author":"A Shigayeva","year":"2016","unstructured":"Shigayeva A, Rudnick W, Green K, et al. Invasive pneumococcal disease among immunocompromised persons: implications for vaccination programs. Clin Infect Dis. 2016;62(2):139\u201347. https:\/\/doi.org\/10.1093\/cid\/civ803.","journal-title":"Clin Infect Dis"},{"key":"5237_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.tmaid.2018.05.016","volume":"24","author":"M van Aalst","year":"2018","unstructured":"van Aalst M, L\u00f6tsch F, Spijker R, et al. Incidence of invasive pneumococcal disease in immunocompromised patients: a systematic review and meta-analysis. Travel Med Infect Dis. 2018;24:89\u2013100. https:\/\/doi.org\/10.1016\/j.tmaid.2018.05.016.","journal-title":"Travel Med Infect Dis"},{"issue":"8","key":"5237_CR4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S1473-3099(09)70175-6","volume":"9","author":"KM Kunisaki","year":"2009","unstructured":"Kunisaki KM, Janoff EN. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis. 2009;9(8):493\u2013504. https:\/\/doi.org\/10.1016\/S1473-3099(09)70175-6.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"5237_CR5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1001\/archinte.161.3.441","volume":"161","author":"JC Lin","year":"2001","unstructured":"Lin JC, Nichol KL. Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome. Arch Intern Med. 2001;161(3):441\u20136. https:\/\/doi.org\/10.1001\/archinte.161.3.441.","journal-title":"Arch Intern Med"},{"issue":"10","key":"5237_CR6","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1001\/jama.281.10.901","volume":"281","author":"KM Neuzil","year":"1999","unstructured":"Neuzil KM, Reed GW, Mitchel EF, Griffin MR. Influenza-associated morbidity and mortality in young and middle-aged women. JAMA. 1999;281(10):901\u20137. https:\/\/doi.org\/10.1001\/jama.281.10.901.","journal-title":"JAMA"},{"issue":"3","key":"5237_CR7","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/00126334-200311010-00008","volume":"34","author":"KM Neuzil","year":"2003","unstructured":"Neuzil KM, Coffey CS, Mitchel EF, Griffin MR. Cardiopulmonary hospitalizations during influenza season in adults and adolescents with advanced HIV infection. J Acquir Immune Defic Syndr. 2003;34(3):304\u20137. https:\/\/doi.org\/10.1097\/00126334-200311010-00008.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"5237_CR8","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41423-023-01087-w","volume":"21","author":"MA H\u00f6ft","year":"2024","unstructured":"H\u00f6ft MA, Burgers WA, Riou C. The immune response to SARS-CoV-2 in people with HIV. Cell Mol Immunol. 2024;21(2):184\u201396. https:\/\/doi.org\/10.1038\/s41423-023-01087-w.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"5237_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-85359-3","volume":"11","author":"P Ssentongo","year":"2021","unstructured":"Ssentongo P, Heilbrunn ES, Ssentongo AE, et al. Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis. Sci Rep. 2021;11(1):6283. https:\/\/doi.org\/10.1038\/s41598-021-85359-3.","journal-title":"Sci Rep"},{"issue":"5","key":"5237_CR10","doi-asserted-by":"publisher","first-page":"e294","DOI":"10.1016\/S2352-3018(21)00070-9","volume":"8","author":"J Ambrosioni","year":"2021","unstructured":"Ambrosioni J, Blanco JL, Reyes-Urue\u00f1a JM, et al. Overview of SARS-CoV-2 infection in adults living with HIV. Lancet HIV. 2021;8(5):e294\u2013305. https:\/\/doi.org\/10.1016\/S2352-3018(21)00070-9.","journal-title":"Lancet HIV"},{"issue":"11","key":"5237_CR11","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.3201\/eid1911.130546","volume":"19","author":"C Cohen","year":"2009","unstructured":"Cohen C, Moyes J, Tempia S, et al. Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa, 2009-2011. Emerg Infect Dis. 2009;19(11):1766\u201374. https:\/\/doi.org\/10.3201\/eid1911.130546.","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"5237_CR12","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1097\/QAD.0000000000003922","volume":"38","author":"C Chambers","year":"2019","unstructured":"Chambers C, Cooper CL, Kroch AE, et al. Coronavirus disease 2019 outcomes in a population-based cohort of people with HIV and a matched cohort of people without HIV during Omicron variant waves. AIDS. 2019;38(10):1597\u2013600. https:\/\/doi.org\/10.1097\/QAD.0000000000003922.","journal-title":"AIDS"},{"issue":"8","key":"5237_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1089\/apc.2014.0121","volume":"28","author":"NF Crum-Cianflone","year":"2014","unstructured":"Crum-Cianflone NF, Wallace MR. Vaccination in HIV-infected adults. AIDS Patient Care STDS. 2014;28(8):397\u2013410. https:\/\/doi.org\/10.1089\/apc.2014.0121.","journal-title":"AIDS Patient Care STDS"},{"issue":"5","key":"5237_CR14","doi-asserted-by":"publisher","first-page":"2054602","DOI":"10.1080\/21645515.2022.2054602","volume":"18","author":"I Kolobova","year":"2022","unstructured":"Kolobova I, Nyaku MK, Karakusevic A, Bridge D, Fotheringham I, O\u2019Brien M. Burden of vaccine-preventable diseases among at-risk adult populations in the US. Hum Vaccin Immunother. 2022;18(5):2054602. https:\/\/doi.org\/10.1080\/21645515.2022.2054602.","journal-title":"Hum Vaccin Immunother"},{"key":"5237_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12070780","author":"H Samaha","year":"2024","unstructured":"Samaha H, Yigitkanli A, Naji A, et al. Burden of vaccine-preventable diseases in people living with HIV. Vaccines. 2024. https:\/\/doi.org\/10.3390\/vaccines12070780.","journal-title":"Vaccines"},{"key":"5237_CR16","unstructured":"Public Health Agency of Canada. Immunization of immunocompromised persons: Canadian Immunization Guide. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-3-vaccination-specific-populations\/page-8-immunization-immunocompromised-persons.html (2018). Accessed 31 Jan 2025."},{"key":"5237_CR17","unstructured":"Public Health Agency of Canada. Vaccination coverage goals and vaccine preventable disease reduction targets by 2025, https:\/\/www.canada.ca\/en\/public-health\/services\/immunization-vaccine-priorities\/national-immunization-strategy\/vaccination-coverage-goals-vaccine-preventable-diseases-reduction-targets-2025.html (2022). Accessed 31 Jan 2025."},{"key":"5237_CR18","unstructured":"Ontario Ministry of Health. Publicly funded immunization schedules for Ontario - June 2022. https:\/\/www.ontario.ca\/files\/2024-01\/moh-publicly-funded-immunization-schedule-en-2024-01-23.pdf (2022). Accessed 31 Jan 2025."},{"key":"5237_CR19","unstructured":"Public Health Agency of Canada. COVID-19 vaccines: Canadian Immunization Guide. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-4-active-vaccines\/page-26-covid-19-vaccine.html (2025). Accessed 31 Jan 2025."},{"issue":"3","key":"5237_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss7003a1","volume":"70","author":"PJ Lu","year":"2018","unstructured":"Lu PJ, Hung MC, Srivastav A, et al. Surveillance of vaccination coverage among adult populations \u2013 United States, 2018. MMWR Surveill Summ. 2018;70(3):1\u201326. https:\/\/doi.org\/10.15585\/mmwr.ss7003a1.","journal-title":"MMWR Surveill Summ"},{"key":"5237_CR21","unstructured":"Ontario Advisory Committee on HIV\/AIDS. Closing the gaps in the HIV care cascade in Ontario. https:\/\/www.ontario.ca\/files\/2023-12\/moh-oacha-hiv-action-plan-en-2023-12-01.pdf (2023). Accessed 14 May 2026."},{"issue":"6","key":"5237_CR22","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1007\/s10461-009-9593-3","volume":"13","author":"VA Earnshaw","year":"2009","unstructured":"Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS Behav. 2009;13(6):1160\u201377. https:\/\/doi.org\/10.1007\/s10461-009-9593-3.","journal-title":"AIDS Behav"},{"issue":"7","key":"5237_CR23","doi-asserted-by":"publisher","first-page":"e011453","DOI":"10.1136\/bmjopen-2016-011453","volume":"6","author":"S Rueda","year":"2016","unstructured":"Rueda S, Mitra S, Chen S, et al. Examining the associations between HIV-related stigma and health outcomes in people living with HIV\/AIDS: a series of meta-analyses. BMJ Open. 2016;6(7):e011453. https:\/\/doi.org\/10.1136\/bmjopen-2016-011453.","journal-title":"BMJ Open"},{"issue":"2","key":"5237_CR24","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/qai.0000000000002570","volume":"86","author":"LM Bogart","year":"2021","unstructured":"Bogart LM, Ojikutu BO, Tyagi K, et al. COVID-19 related medical mistrust, health impacts, and potential vaccine hesitancy among Black Americans living with HIV. J Acquir Immune Defic Syndr. 2021;86(2):200\u20137. https:\/\/doi.org\/10.1097\/qai.0000000000002570.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"5237_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/vaccines12030269","volume":"12","author":"J Etowa","year":"2024","unstructured":"Etowa J, Beauchamp S, Fseifes M, et al. Understanding low vaccine uptake in the context of public health in high-income countries: a scoping review. Vaccines (Basel). 2024;12(3):269. https:\/\/doi.org\/10.3390\/vaccines12030269.","journal-title":"Vaccines (Basel)"},{"key":"5237_CR26","volume-title":"Position statement: a provincial immunization registry for Ontario","author":"Ontario Agency for Health Protection and Promotion (Public Health Ontario), Ontario Immunization Advisory Committee","year":"2024","unstructured":"Ontario Agency for Health Protection and Promotion (Public Health Ontario), Ontario Immunization Advisory Committee. Position statement: a provincial immunization registry for Ontario. Toronto: King\u2019s Printer for Ontario; 2024."},{"key":"5237_CR27","unstructured":"Public Health Agency of Canada. HIV in Canada - People living with HIV and new HIV infections, 2020. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/hiv-canada-people-living-with-hiv-new-infections-2020.html (2022). Accessed 31 Jan 2025."},{"key":"5237_CR28","unstructured":"Ontario HIV Epidemiology and Surveillance Initiative. HIV care cascade in Ontario: Linkage to care, in care, on antiretroviral treatment, and virally suppressed, 2020. https:\/\/www.ohesi.ca\/wp-content\/uploads\/2022\/10\/HIV-Care-Cascade-2020-final-1.pdf (2022). Accessed 31 Jan 2025."},{"issue":"2","key":"5237_CR29","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/ije\/dyr230","volume":"42","author":"SB Rourke","year":"2013","unstructured":"Rourke SB, Gardner S, Burchell AN, et al. Cohort profile: the Ontario HIV Treatment Network Cohort Study (OCS). Int J Epidemiol. 2013;42(2):402\u201311. https:\/\/doi.org\/10.1093\/ije\/dyr230.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"5237_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2307\/2137284","volume":"36","author":"RM Andersen","year":"1995","unstructured":"Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36(1):1\u201310.","journal-title":"J Health Soc Behav"},{"key":"5237_CR31","doi-asserted-by":"publisher","DOI":"10.3205\/psm000089","author":"B Babitsch","year":"2012","unstructured":"Babitsch B, Gohl D, von Lengerke T. Re-revisiting Andersen\u2019s Behavioral Model of Health Services Use: A systematic review of studies from 1998\u20132011. Psychosoc Med. 2012. https:\/\/doi.org\/10.3205\/psm000089.","journal-title":"Psychosoc Med"},{"key":"5237_CR32","unstructured":"Ontario HIV Epidemiology and Surveillance Initiative. HIV epidemiology update for gay, bisexual, and other men who have sex with men (GBMSM) in Ontario, 2019, https:\/\/www.ohesi.ca\/wp-content\/uploads\/2022\/05\/GBMSM-Factsheet-ENGLISH-2022MAY04.pdf (2022). Accessed 31 Jan 2025."},{"issue":"6","key":"5237_CR33","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","volume":"88","author":"JB Saunders","year":"1993","unstructured":"Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption \u2013 II. Addiction. 1993;88(6):791\u2013804. https:\/\/doi.org\/10.1111\/j.1360-0443.1993.tb02093.x.","journal-title":"Addiction"},{"issue":"10","key":"5237_CR34","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jclinepi.2012.04.007","volume":"65","author":"A Moser","year":"2012","unstructured":"Moser A, Stuck AE, Silliman RA, Ganz PA, Clough-Gorr KM. The eight-item modified Medical Outcomes Study Social Support Survey: psychometric evaluation showed excellent performance. J Clin Epidemiol. 2012;65(10):1107\u201316. https:\/\/doi.org\/10.1016\/j.jclinepi.2012.04.007.","journal-title":"J Clin Epidemiol"},{"key":"5237_CR35","volume-title":"User\u2019s manual for the SF-12 v2 health survey","author":"J Ware","year":"2007","unstructured":"Ware J, Kosinski M, Turner-Bowker D, Gandeck M. User\u2019s manual for the SF-12 v2 health survey. Lincoln: QualityMetric Inc.; 2007."},{"issue":"11","key":"5237_CR36","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2471\/BLT.09.067231","volume":"88","author":"TB Ust\u00fcn","year":"2010","unstructured":"Ust\u00fcn TB, Chatterji S, Kostanjsek N, et al. Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Organ. 2010;88(11):815\u201323. https:\/\/doi.org\/10.2471\/BLT.09.067231.","journal-title":"Bull World Health Organ"},{"issue":"7","key":"5237_CR37","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","volume":"159","author":"G Zou","year":"2004","unstructured":"Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702\u20136. https:\/\/doi.org\/10.1093\/aje\/kwh090.","journal-title":"Am J Epidemiol"},{"key":"5237_CR38","unstructured":"Public Health Agency of Canada. Adult National Immunization Coverage Survey (aNICS): 2023 results. https:\/\/www.canada.ca\/en\/public-health\/services\/immunization-vaccines\/vaccination-coverage\/adult-national-immunization-coverage-survey-2023-results.html (2024). Accessed 31 Jan 2025."},{"issue":"1","key":"5237_CR39","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/21645515.2019.1632683","volume":"16","author":"J Vietri","year":"2020","unstructured":"Vietri J, Harnett J, Emir B, Chilson E. Uptake of 13-valent pneumococcal conjugate vaccine among US adults aged 19 to 64 years with immunocompromising conditions. Hum Vaccin Immunother. 2020;16(1):161\u20138. https:\/\/doi.org\/10.1080\/21645515.2019.1632683.","journal-title":"Hum Vaccin Immunother"},{"issue":"10","key":"5237_CR40","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.3390\/vaccines10101654","volume":"10","author":"S Shapiro Ben David","year":"2022","unstructured":"Shapiro Ben David S, Goren I, Mourad V, Cahan A. Vaccination coverage among immunocompromised patients in a large health maintenance organization: findings from a novel computerized registry. Vaccines. 2022;10(10):1654. https:\/\/doi.org\/10.3390\/vaccines10101654.","journal-title":"Vaccines"},{"issue":"1","key":"5237_CR41","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1080\/14760584.2023.2226718","volume":"22","author":"J Liu","year":"2023","unstructured":"Liu J, Johnson KD, Shoener Dunham L. Pneumococcal vaccination coverage among US adults enrolled in Medicaid and newly diagnosed with underlying medical conditions. Expert Rev Vaccines. 2023;22(1):596\u2013607. https:\/\/doi.org\/10.1080\/14760584.2023.2226718.","journal-title":"Expert Rev Vaccines"},{"issue":"9","key":"5237_CR42","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1080\/21645515.2020.1763739","volume":"16","author":"L Boey","year":"2020","unstructured":"Boey L, Bosmans E, Ferreira LB, et al. Vaccination coverage of recommended vaccines and determinants of vaccination in at-risk groups. Hum Vaccin Immunother. 2020;16(9):2136\u201343. https:\/\/doi.org\/10.1080\/21645515.2020.1763739.","journal-title":"Hum Vaccin Immunother"},{"issue":"33","key":"5237_CR43","doi-asserted-by":"publisher","first-page":"4856","DOI":"10.1016\/j.vaccine.2022.06.068","volume":"40","author":"A Ostropolets","year":"2022","unstructured":"Ostropolets A, Shoener Dunham L, Johnson KD, Liu J. Pneumococcal vaccination coverage among adults newly diagnosed with underlying medical conditions and regional variation in the U.S. Vaccine. 2022;40(33):4856\u201363. https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.068.","journal-title":"Vaccine"},{"issue":"1","key":"5237_CR44","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/cid\/ciad106","volume":"77","author":"BM Imp","year":"2023","unstructured":"Imp BM, Levine T, Satre DD, et al. Influenza vaccination uptake and associated factors among adults with and without human immunodeficiency virus in a large, integrated healthcare system. Clin Infect Dis. 2023;77(1):56\u201363. https:\/\/doi.org\/10.1093\/cid\/ciad106.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"5237_CR45","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1080\/21645515.2021.1894895","volume":"17","author":"L Larsen","year":"2021","unstructured":"Larsen L, Nguyen MTT, Johansen IS. The coverage of influenza and pneumococcal vaccinations among people living with HIV in Denmark: a single-center cross-sectional survey. Hum Vaccin Immunother. 2021;17(8):2700\u20135. https:\/\/doi.org\/10.1080\/21645515.2021.1894895.","journal-title":"Hum Vaccin Immunother"},{"issue":"17","key":"5237_CR46","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1016\/j.vaccine.2024.04.077","volume":"42","author":"A Kolakowska","year":"2024","unstructured":"Kolakowska A, Marshall E, Krastinova E, et al. Insufficient vaccine coverage and vaccine hesitancy in people living with HIV: a prospective study in outpatient clinics in the Paris region. Vaccine. 2024;42(17):3655\u201363. https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.077.","journal-title":"Vaccine"},{"issue":"7","key":"5237_CR47","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/hiv.12483","volume":"18","author":"N Harrison","year":"2017","unstructured":"Harrison N, Poeppl W, Herkner H, et al. Predictors for and coverage of influenza vaccination among HIV-positive patients: a cross-sectional survey. HIV Med. 2017;18(7):500\u20136. https:\/\/doi.org\/10.1111\/hiv.12483.","journal-title":"HIV Med"},{"issue":"35","key":"5237_CR48","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1016\/j.vaccine.2014.06.015","volume":"32","author":"F Valour","year":"2009","unstructured":"Valour F, Cotte L, Voirin N, et al. Vaccination coverage against hepatitis A and B viruses, Streptococcus pneumoniae, seasonal flu, and A(H1N1)2009 pandemic influenza in HIV-infected patients. Vaccine. 2009;32(35):4558\u201364. https:\/\/doi.org\/10.1016\/j.vaccine.2014.06.015.","journal-title":"Vaccine"},{"issue":"5-6","key":"5237_CR49","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ypmed.2010.03.007","volume":"50","author":"KN Althoff","year":"2006","unstructured":"Althoff KN, Anastos K, Nelson KE, et al. Predictors of reported influenza vaccination in HIV-infected women in the United States, 2006-2007 and 2007-2008 seasons. Prev Med. 2006;50(5\u20136):223\u20139. https:\/\/doi.org\/10.1016\/j.ypmed.2010.03.007.","journal-title":"Prev Med"},{"issue":"5","key":"5237_CR50","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/hiv.12309","volume":"17","author":"J Ellis","year":"2016","unstructured":"Ellis J, Brown J, Smith C, et al. Influenza immunisation: knowledge and actions taken by UK HIV-positive adults. HIV Med. 2016;17(5):397\u20139. https:\/\/doi.org\/10.1111\/hiv.12309.","journal-title":"HIV Med"},{"key":"5237_CR51","volume-title":"COVID-19 vaccine uptake in Ontario: December 14, 2020 to September 10, 2023","author":"Ontario Agency for Health Protection and Promotion (Public Health Ontario)","year":"2023","unstructured":"Ontario Agency for Health Protection and Promotion (Public Health Ontario). COVID-19 vaccine uptake in Ontario: December 14, 2020 to September 10, 2023. Toronto: King\u2019s Printer for Ontario; 2023."},{"key":"5237_CR52","doi-asserted-by":"publisher","unstructured":"Freitas C, Cooper C, Kroch AE, et al. COVID-19 vaccine uptake in a retrospective population-based cohort of people living with and without HIV in Ontario, Canada. Vaccine. 2025;61:127422. https:\/\/doi.org\/10.1016\/j.vaccine.2025.127422","DOI":"10.1016\/j.vaccine.2025.127422"},{"issue":"8","key":"5237_CR53","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1007\/s10461-023-03991-8","volume":"27","author":"CT Costiniuk","year":"2023","unstructured":"Costiniuk CT, Singer J, Needham J, et al. Understanding COVID-19 vaccine confidence in people living with HIV: a pan-Canadian survey. AIDS Behav. 2023;27(8):2669\u201380. https:\/\/doi.org\/10.1007\/s10461-023-03991-8.","journal-title":"AIDS Behav"},{"key":"5237_CR54","doi-asserted-by":"publisher","first-page":"106329","DOI":"10.1016\/j.ypmed.2020.106329","volume":"143","author":"R Grewal","year":"2021","unstructured":"Grewal R, Grennan T, Gillis JL, et al. Low human papillomavirus (HPV) vaccine uptake among men living with human immunodeficiency virus (HIV): cross-sectional findings from a clinical cohort. Prev Med. 2021;143:106329. https:\/\/doi.org\/10.1016\/j.ypmed.2020.106329.","journal-title":"Prev Med"},{"key":"5237_CR55","doi-asserted-by":"publisher","first-page":"107246","DOI":"10.1016\/j.ypmed.2022.107246","volume":"164","author":"C Chambers","year":"2022","unstructured":"Chambers C, Gillis J, Lindsay J, et al. Low human papillomavirus vaccine uptake among women engaged in HIV care in Ontario, Canada. Prev Med. 2022;164:107246. https:\/\/doi.org\/10.1016\/j.ypmed.2022.107246.","journal-title":"Prev Med"},{"key":"5237_CR56","unstructured":"Ontario Ministry of Finance. Ontario demographic quarterly: Highlights of first quarter, https:\/\/www.ontario.ca\/page\/ontario-demographic-quarterly-highlights-first-quarter (2025). Accessed 31 Jan 2025."},{"key":"5237_CR57","unstructured":"Canadian HIV Trials Network. HIV and aging, https:\/\/www.hivnet.ubc.ca\/knowledge-center\/hiv-aging\/ (2025). Accessed 31 Jan 2025."},{"key":"5237_CR58","unstructured":"Giliauskas D, Gogolishvili D. Rapid response service. Unmet needs of Indigenous peoples living with HIV, https:\/\/www.ohtn.on.ca\/rapid-response-unmet-needs-of-indigenous-peoples-living-with-hiv\/ (2019). Accessed 31 Jan 2025."},{"key":"5237_CR59","unstructured":"Ontario HIV Epidemiology and Surveillance Initiative. HIV and women in Ontario, https:\/\/www.ohesi.ca\/wp-content\/uploads\/2021\/12\/OHESI-WHAI-Fact-Sheet-Women-HIV-Ontario.pdf (2021). Accessed 31 Jan 2025."},{"issue":"2","key":"5237_CR60","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1056\/NEJMp2103104","volume":"385","author":"SC Quinn","year":"2021","unstructured":"Quinn SC, Andrasik MP. Addressing vaccine hesitancy in BIPOC communities \u2013 toward trustworthiness, partnership, and reciprocity. N Engl J Med. 2021;385(2):97\u2013100. https:\/\/doi.org\/10.1056\/NEJMp2103104.","journal-title":"N Engl J Med"},{"issue":"8","key":"5237_CR61","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.vaccine.2018.01.025","volume":"36","author":"L Wilson","year":"2018","unstructured":"Wilson L, Rubens-Augustson T, Murphy M, et al. Barriers to immunization among newcomers: a systematic review. Vaccine. 2018;36(8):1055\u201362. https:\/\/doi.org\/10.1016\/j.vaccine.2018.01.025.","journal-title":"Vaccine"},{"issue":"10077","key":"5237_CR62","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/s0140-6736(17)30569-x","volume":"389","author":"ZD Bailey","year":"2017","unstructured":"Bailey ZD, Krieger N, Ag\u00e9nor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453\u201363. https:\/\/doi.org\/10.1016\/s0140-6736(17)30569-x.","journal-title":"Lancet"},{"issue":"7","key":"5237_CR63","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1007\/s10461-024-04351-w","volume":"28","author":"M Pereira","year":"2024","unstructured":"Pereira M, Santos Aleluia IR, de Castro CT, et al. COVID-19 vaccine acceptance and hesitancy among people living with HIV: review and meta-analysis. AIDS Behav. 2024;28(7):2193\u2013204. https:\/\/doi.org\/10.1007\/s10461-024-04351-w.","journal-title":"AIDS Behav"},{"issue":"7","key":"5237_CR64","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1007\/s10461-024-04344-9","volume":"28","author":"X Liu","year":"2024","unstructured":"Liu X, Wu Y, Huo Z, et al. COVID-19 vaccine hesitancy among people living with HIV: a systematic review and meta-analysis. AIDS Behav. 2024;28(7):2183\u201392. https:\/\/doi.org\/10.1007\/s10461-024-04344-9.","journal-title":"AIDS Behav"},{"key":"5237_CR65","unstructured":"World Health Organization. Vaccination schedule for pneumococcal disease, https:\/\/immunizationdata.who.int\/global\/wiise-detail-page\/vaccination-schedule-for-pneumococcal-disease (2025). Accessed 31 January 2025."},{"key":"5237_CR66","unstructured":"Ontario Agency for Health Protection and Promotion (Public Health Ontario). COVID-19 in Ontario \u2013 a focus on neighbourhood diversity: February 26, 2020 to December 31, 2022. Toronto, ON: King\u2019s Printer for Ontario; 2023."},{"issue":"34","key":"5237_CR67","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1016\/j.vaccine.2015.04.036","volume":"33","author":"NE MacDonald","year":"2015","unstructured":"MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161\u20134. https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.036.","journal-title":"Vaccine"},{"issue":"12","key":"5237_CR68","doi-asserted-by":"publisher","first-page":"e0208601","DOI":"10.1371\/journal.pone.0208601","volume":"13","author":"C Betsch","year":"2018","unstructured":"Betsch C, Schmid P, Heinemeier D, Korn L, Holtmann C, B\u00f6hm R. Beyond confidence: development of a measure assessing the 5C psychological antecedents of vaccination. PLoS ONE. 2018;13(12):e0208601. https:\/\/doi.org\/10.1371\/journal.pone.0208601.","journal-title":"PLoS ONE"},{"issue":"1","key":"5237_CR69","doi-asserted-by":"publisher","first-page":"2204785","DOI":"10.1080\/21645515.2023.2204785","volume":"19","author":"NK Birk","year":"2023","unstructured":"Birk NK, Monday L, Singh T, et al. Vaccine coverage and factors associated with vaccine adherence in persons with HIV at an urban infectious disease clinic. Hum Vaccin Immunother. 2023;19(1):2204785. https:\/\/doi.org\/10.1080\/21645515.2023.2204785.","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"5237_CR70","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1080\/21645515.2020.1802163","volume":"17","author":"TM Johnson","year":"2021","unstructured":"Johnson TM, Klepser DG, Bares SH, Scarsi KK. Predictors of vaccination rates in people living with HIV followed at a specialty care clinic. Hum Vaccin Immunother. 2021;17(3):791\u20136. https:\/\/doi.org\/10.1080\/21645515.2020.1802163.","journal-title":"Hum Vaccin Immunother"},{"issue":"37","key":"5237_CR71","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.1016\/j.vaccine.2013.06.041","volume":"31","author":"SJ Rolnick","year":"2013","unstructured":"Rolnick SJ, Parker ED, Nordin JD, et al. Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors? Vaccine. 2013;31(37):3928\u201335. https:\/\/doi.org\/10.1016\/j.vaccine.2013.06.041.","journal-title":"Vaccine"},{"issue":"11","key":"5237_CR72","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1016\/j.vaccine.2024.03.052","volume":"42","author":"MF Daley","year":"2024","unstructured":"Daley MF, Reifler LM, Shoup JA, et al. Influenza vaccination accuracy among adults: self-report compared with electronic health record data. Vaccine. 2024;42(11):2740\u20136. https:\/\/doi.org\/10.1016\/j.vaccine.2024.03.052.","journal-title":"Vaccine"},{"issue":"2","key":"5237_CR73","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/hiv.12682","volume":"20","author":"CE Kendall","year":"2019","unstructured":"Kendall CE, Raboud J, Donelle J, et al. Lost but not forgotten: a population-based study of mortality and care trajectories among people living with HIV who are lost to follow-up in Ontario, Canada. HIV Med. 2019;20(2):88\u201398. https:\/\/doi.org\/10.1111\/hiv.12682.","journal-title":"HIV Med"},{"key":"5237_CR74","unstructured":"Ontario Agency for Health Protection and Promotion (Public Health Ontario). Immunization coverage report for school pupils in Ontario: 2019\u201320 to 2022\u201323 school years. Toronto, ON: King\u2019s Printer for Ontario; 2024."},{"key":"5237_CR75","unstructured":"LaPenna R, Gogolishvili D. Ontario HIV Treatment Network (OHTN) Rapid Response Service. Models of primary health care for people living with HIV, https:\/\/www.ohtn.on.ca\/wp-content\/uploads\/2026\/01\/RR_190-Models-of-primary-care-for-people-living-with-HIV_final.pdf (2026). Accessed 14 May 2026."}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05237-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-026-05237-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05237-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:15:14Z","timestamp":1784610914000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-026-05237-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":75,"alternative-id":["5237"],"URL":"https:\/\/doi.org\/10.1007\/s10461-026-05237-9","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"27 June 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RG is an Assistant Professor at the Centre for Vaccine Preventable Diseases (CVPD) at the University of Toronto. The CVPD receives operational support from a mix of funding sources, including through donations from pharmaceutical companies. A robust set of governance practices are in place to safeguard the academic freedom of the CVPD. RG holds the Sanofi Early Career Investigator in Vaccine Access Research at the University of Toronto. All other authors declare no conflicts of interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}